

Please try another search
The United States has administered 329,970,551 doses of COVID-19 vaccines in the country as of Saturday morning and distributed 383,067,560 doses, the U.S. Centers for Disease Control and Prevention said on Saturday.
Those figures are up from the 328,809,470 vaccine doses the CDC said had gone into arms by July 2 out of 382,636,520 doses delivered.
The agency said 182,109,860 people had received at least one dose while 156,982,549 people are fully vaccinated as of Saturday.
The CDC tally includes two-dose vaccines from Moderna (NASDAQ:MRNA) and Pfizer/BioNTech, as well as Johnson & Johnson (NYSE:JNJ)'s one-shot vaccine as of 6:00 a.m. ET on Saturday.
By Andrea Shalal WASHINGTON (Reuters) - Oxfam America, Partners in Health and other civil society groups urged U.S. President Joe Biden to press for changes in a draft agreement...
(Bloomberg) -- Beijing reported a record number of Covid cases during its current outbreak, reviving concern the capital may face a lockdown as authorities seek to stamp out...
By Brenda Goh and Martin Quin Pollard SHANGHAI/BEIJING (Reuters) - Shanghai reopened a small part of the world's longest subway system on Sunday after some lines had been closed...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.